A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment. The study noted that cognitive functioning varies across survivors, with some reporting no impairments and others reporting more severe or pervasive deficits. The objective of this analysis was to clarify existing research on cognitive functioning in patients who had received standard dose chemotherapy for breast cancer at least six months previously. Read more here.
Study mentioned: Jim HS, et al. Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy. J Clin Oncol. 2012 Aug 27. [Epub ahead of print] PMID: 22927526
No comments:
Post a Comment